Taylor James M, Song Andrew, Nowak Kamila, Dan Tu, Simone Brittany, Harrison Amy, Doyle Laura, Lockamy Virginia, Anne Pramila, Simone Nicole
Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, USA.
Cureus. 2021 Feb 15;13(2):e13354. doi: 10.7759/cureus.13354.
Background The COVID-19 pandemic challenges our ability to safely treat breast cancer patients and requires revisiting current techniques to evaluate optimal strategies. Potential long-term sequelae of breast radiation have been addressed by deep inspiration breath-hold (DIBH), prone positioning, and four-dimensional computed tomography (4DCT) average intensity projection (AveIP)-based planning techniques. Dosimetric comparisons to determine the optimal technique to minimize the normal tissue dose for left-sided breast cancers have not been performed. Methods Ten patients with left-sided, early-stage breast cancer undergoing whole breast radiation were simulated in the prone position, supine with DIBH, and with a free-breathing 4DCT scan. The target and organs at risk (OAR) contours were delineated in all scans. Target volume coverage and OAR doses were assessed. One-way analysis of variance (ANOVA) and Kruskal-Wallis one-way ANOVA were used to detect differences in dosimetric parameters among the different treatment plans. Significance was set as p < 0.05. Results We demonstrate differences in heart and lung dose by the simulation technique. The mean heart doses in the prone, DIBH, and AveIP plans were 129 cGy, 154 cGy, and 262 cGy, respectively (p=0.02). The lung V20 in the prone, DIBH, and AveIP groups was 0.5%, 10.3% and 9.5%, respectively (p <0.001). Regardless of technique, lumpectomy planning target volume (PTV) coverage did not differ between the three plans with 95% of the lumpectomy PTV volume covered by 100.4% in prone plans, 98.5% in AveIP plans, and 99.3% in DIBH plans (p=0.7). Conclusions Prone positioning provides dosimetric advantages as compared to DIBH. When infection risks are considered as in the current coronavirus disease 2019 (COVID-19) pandemic, prone plans have advantages in reducing the risk of disease transmission. In instances where prone positioning is not feasible, obtaining an AveIP simulation may be useful in more accurately assessing heart and lung toxicity and informing a risk/benefit discussion of DIBH vs free breath-hold techniques.
2019冠状病毒病(COVID-19)大流行对我们安全治疗乳腺癌患者的能力构成挑战,需要重新审视当前技术以评估最佳策略。深吸气屏气(DIBH)、俯卧位以及基于四维计算机断层扫描(4DCT)平均强度投影(AveIP)的计划技术已解决了乳腺放疗可能产生的长期后遗症问题。尚未进行剂量学比较以确定将左侧乳腺癌正常组织剂量降至最低的最佳技术。
对10例接受全乳放疗的左侧早期乳腺癌患者进行模拟,分别采用俯卧位、DIBH仰卧位以及自由呼吸4DCT扫描。在所有扫描中勾画靶区和危及器官(OAR)轮廓。评估靶区体积覆盖情况和OAR剂量。采用单因素方差分析(ANOVA)和Kruskal-Wallis单因素方差分析检测不同治疗计划之间剂量学参数的差异。显著性设定为p<0.05。
我们证明了模拟技术在心脏和肺部剂量方面存在差异。俯卧位、DIBH和AveIP计划中的平均心脏剂量分别为129 cGy、154 cGy和262 cGy(p=0.02)。俯卧位、DIBH和AveIP组的肺V20分别为0.5%、10.3%和9.5%(p<0.001)。无论采用何种技术,三种计划之间保乳手术计划靶区(PTV)覆盖情况无差异,俯卧位计划中95%的保乳手术PTV体积被100.4%覆盖,AveIP计划中为98.5%,DIBH计划中为99.3%(p=0.7)。
与DIBH相比,俯卧位具有剂量学优势。在当前COVID-19大流行中考虑感染风险时,俯卧位计划在降低疾病传播风险方面具有优势。在俯卧位不可行的情况下,进行AveIP模拟可能有助于更准确地评估心脏和肺部毒性,并为DIBH与自由屏气技术的风险/获益讨论提供参考。